Comparison of complications between Broviacs® and PICCs in children

0

This study compares complications between Broviacs® and PICCs in children with IF” Blotte et al (2017).

Abstract:

PURPOSE: Central venous catheters (CVCs) are a source of morbidity for children with intestinal failure (IF). Complications include infection, breakage, occlusion, and venous thrombosis. Broviacs® have traditionally been preferred, but peripherally inserted central catheters (PICCs) are gaining popularity. This study compares complications between Broviacs® and PICCs in children with IF.

METHODS: After IRB approval, children with IF receiving parenteral nutrition (2012-2016) were reviewed. Complications were compared between Broviacs® and PICCs using the generalized estimation equation population-averaged Poisson regression model. P values

RESULTS: 36 children (0.1-16years) with IF were reviewed, accounting for 27,331 catheter days, 108 Broviacs® (3F-9F), and 54 PICCs (2-11F). Broviacs® had a significantly higher infection rate (4.2 vs. 2.6/1000 catheter days, p=0.011), but PICCs were more likely to break (1.56 vs. 0.26/1000 catheter days, p=0.002). When comparing same size catheters (3F), there were no significant differences in infection, breakage, or occlusion. Twelve children (33%) had central venous thrombosis, all after Broviac® placement. Three children (8%) had basilic vein thrombosis after PICC placement.

CONCLUSION: Although Broviacs® and PICCs had similar complication rates, there were fewer central venous thromboses associated with PICCs. This should be considered when choosing catheters for children with IF.

LEVEL OF EVIDENCE: 11b (Prognosis Study).

Reference:

Blotte, C., Styers, J., Zhu, H., Channabasappa, N. and Piper, H.G. (2017) A comparison of Broviac® and peripherally inserted central catheters in children with intestinal failure. Journal of Pediatric Surgery. January 29th. [Epub ahead of print].

doi: 10.1016/j.jpedsurg.2017.01.036.

Thank you to our partners for supporting IVTEAM

Other stories

Loading…

Share.

Comments are closed.